Hi, what are you looking for?
After a successful ballot measure, a broad set of onlookers focuses on Oregon to gauge the social and economic impacts of licensed psilocybin therapy
Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine
A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound
In September, the Michigan city halted enforcement related to all entheogenic plants. Officials hope the move will inspire other moderate jurisdictions
Psychedelics and holistic products can help battle the mental health crisis, says Rritual president Dr. Mike Hart
Extracting psilocybin from magic mushrooms will be cheaper than current method of creating synthetic compound for research, says company